Hospital
ST Lukes - ST Vincents Healthcare
ST Lukes - ST Vincents Healthcare was paid $4.92M by Medicaid between Jun 2021 and Dec 2024, across 135 billing codes. Its largest line is 99283, emergency room visit (moderate) — 33% of everything it billed.
33Billing provider infoST LUKES - ST VINCENTS HEALTHCARE
JACKSONVILLE, FL 32216
JACKSONVILLE, FL 32216
33aNPI1457005720assigned 02/07/2022
33bProvider typeRehabilitation Hospital Unit
28Total paid$4.92M
24GClaims107,161
24DCodes billed135
24AFirst – last monthJun 2021 – Dec 2024
Compared with peers
Next to other Rehabilitation Hospital Unit providers in Florida
Rank by total paid#9 of 11
Median peer was paid$15.92M
This provider vs. median0.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official QUIRICONI, STEPHAN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 894 | $29K | |
| 2022 | 64,967 | $2.42M | |
| 2023 | 34,251 | $1.90M | |
| 2024incomplete | 7,049 | $569K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 33% | 13,680 | 12,727 | $1.61M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 30% | 6,995 | 6,134 | $1.48M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 19% | 6,167 | 5,668 | $953K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.9% | 1,686 | 1,591 | $193K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 3.0% | 482 | 438 | $146K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 1.6% | 261 | 216 | $78K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1.2% | 413 | 159 | $58K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.1% | 4,241 | 4,052 | $54K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.1% | 587 | 566 | $52K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 600 | 565 | $38K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 43 | 38 | $25K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 364 | 346 | $24K |
123 more codes
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 148 | $21K |
| 76642 | <1% | 221 | $21K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 628 | $15K |
| 59025 | Fetal non-stress test | <1% | 861 | $14K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 546 | $13K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 27 | $12K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 652 | $12K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 984 | $10K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 203 | $9K |
| G0378 | Hospital observation service, per hour | <1% | 814 | $9K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 226 | $7K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 750 | $5K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 4,331 | $5K |
| 72100 | <1% | 197 | $5K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,297 | $4K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,628 | $4K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 372 | $4K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 212 | $4K |
| 93017 | <1% | 106 | $3K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 3,101 | $2K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 372 | $2K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 202 | $2K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,165 | $2K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 141 | $2K |
| 73562 | <1% | 147 | $2K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 394 | $2K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 50 | $1K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 14 | $1K |
| 94726 | <1% | 13 | $1K | |
| J2704 | Injection, propofol, 10 mg | <1% | 817 | $1K |
| 73630 | <1% | 181 | $1K | |
| A9270 | Non-covered item or service | <1% | 1,165 | $952.09 |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 79 | $940.90 |
| 80053 | Comprehensive metabolic panel | <1% | 4,739 | $896.37 |
| 93971 | <1% | 50 | $881.98 | |
| 76830 | Ultrasound, transvaginal | <1% | 418 | $771.10 |
| 72040 | <1% | 46 | $756.57 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,191 | $678.49 |
| 76801 | <1% | 229 | $647.41 | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 261 | $634.57 |
| 76536 | <1% | 12 | $616.34 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 440 | $575.59 |
| 77066 | Tomosynthesis, mammo | <1% | 89 | $574.83 |
| 71250 | <1% | 27 | $521.84 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 6,613 | $474.03 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 66 | $455.41 |
| 71045 | Radiologic examination, chest; single view | <1% | 2,163 | $432.67 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 819 | $429.66 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 302 | $425.76 |
| 73030 | <1% | 137 | $416.82 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 465 | $405.14 |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,612 | $403.90 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 31 | $383.04 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 130 | $383.04 |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 30 | $359.60 |
| 73130 | <1% | 99 | $199.02 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,266 | $188.52 |
| 82077 | <1% | 133 | $185.53 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 399 | $164.61 |
| 81001 | <1% | 2,798 | $143.46 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 315 | $122.66 |
| 77062 | <1% | 64 | $95.25 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 15 | $86.23 |
| 81025 | <1% | 2,015 | $76.99 | |
| 73610 | <1% | 126 | $73.07 | |
| 81003 | <1% | 976 | $70.50 | |
| 84484 | <1% | 1,510 | $70.16 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,195 | $63.90 |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 226 | $63.88 |
| 83880 | <1% | 283 | $56.98 | |
| 73110 | <1% | 39 | $53.78 | |
| 87210 | <1% | 518 | $51.70 | |
| 74018 | <1% | 25 | $36.77 | |
| 82962 | <1% | 584 | $35.52 | |
| 86703 | <1% | 71 | $35.41 | |
| 94762 | <1% | 39 | $33.43 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,326 | $31.50 |
| 85610 | <1% | 400 | $18.62 | |
| 85730 | <1% | 294 | $18.62 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 412 | $16.67 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,380 | $16.19 |
| 86901 | <1% | 600 | $15.93 | |
| 83690 | <1% | 1,248 | $12.82 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 412 | $8.34 |
| 83605 | <1% | 392 | $7.79 | |
| 86803 | <1% | 59 | $6.52 | |
| 86900 | <1% | 518 | $5.19 | |
| 86850 | <1% | 385 | $5.19 | |
| 80061 | Lipid panel | <1% | 44 | $5.17 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 494 | $4.97 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,402 | $4.97 |
| 83735 | <1% | 328 | $4.69 | |
| 84703 | <1% | 875 | $4.69 | |
| 85379 | <1% | 190 | $4.64 | |
| 84702 | <1% | 458 | $4.05 | |
| 81002 | <1% | 16 | $3.12 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 199 | $0.00 |
| 87186 | 0% | 55 | $0.00 | |
| J0153 | Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 0% | 18 | $0.00 |
| 87634 | 0% | 426 | $0.00 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 12 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 133 | $0.00 |
| 72131 | 0% | 15 | $0.00 | |
| 94729 | 0% | 13 | $0.00 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 0% | 36 | $0.00 |
| J1644 | Injection, heparin sodium, per 1000 units | 0% | 98 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 139 | $0.00 |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 189 | $0.00 |
| 96376 | 0% | 332 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 402 | $0.00 |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 58 | $0.00 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 0% | 16 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 161 | $0.00 |
| 82550 | 0% | 64 | $0.00 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 132 | $0.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 0% | 56 | $0.00 |
| 87040 | 0% | 100 | $0.00 | |
| 86140 | 0% | 16 | $0.00 | |
| 87077 | 0% | 52 | $0.00 | |
| 88342 | 0% | 16 | $0.00 | |
| 87205 | 0% | 17 | $0.00 | |
| J2060 | Injection, lorazepam, 2 mg | 0% | 12 | $0.00 |
| 85027 | 0% | 32 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialQUIRICONI, STEPHAN (CHIEF FINANCIAL OFFICER)
Parent organizationST LUKES - ST VINCENTS HEALTHCARE
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.